Marseille, 7 July 2026 – How can patients be involved in the research and innovation projects led by Marseille Immunology Biocluster? This was the central question addressed by the first participants in MIB’s Patient Partnership Working Group, who met on 26 June at IMéRA, located in Marseille’s Palais Longchamp. This inaugural session brought together patient […]
MIB Startup Studio launches its first call for applications to support immunology startups
Marseille, 6 July 2026 – Marseille Immunology Biocluster has launched the first call for applications for MIB Startup Studio, an initiative designed to support immunology startups in their scientific, strategic and entrepreneurial development. Created to support high-potential projects, MIB Startup Studio is aimed at established startups seeking to accelerate their development by connecting with a […]
SAB Voices: Pedro Romero on Why Marseille is Becoming a Hub for Translational Immunology
Marseille, June 30, 2026 – Professor Pedro Romero, the chair of the Scientific Advisory Board of Marseille Immunology Biocluster, once thought his future lay in nuclear physics. Growing up in Colombia, he was fascinated by fundamental science and initially imagined a career studying particles and reactors. But there was a practical problem. Colombia didn’t have […]
MIB joins France BioLead to strengthen France’s biomanufacturing ecosystem for biomedicines
Marseille, July 2026 – Marseille Immunology Biocluster has become a member of France BioLead, the national accelerator and representative of France’s biomanufacturing ecosystem for biomedicines. This membership marks an important step in MIB’s commitment to strengthening a sovereign, innovative and collaborative healthcare ecosystem in France. It places the biocluster within a national momentum aimed at […]
NANOLOGIC x Cell-Scale: Engineering Precision CAR-T for Solid Tumors
Marseille, April 14 2026 – Interview with Rémi Lasserre, Inserm Researcher at CRCM Marseille. At the Cancer Research Center of Marseille (CRCM), Inserm researcher Rémi Lasserre focuses on lymphocytes and how they can be engineered into powerful therapeutic tools. He is currently collaborating with the Cell-Scale platform, within MIB, to develop next-generation CAR-T cells designed […]
The Beacon Installed on the B-SCREEN Platform at IHU Méditerranée Infection
Accelerating innovation in infectious diseases requires building strong bridges between patient-derived samples, cutting-edge research, and therapeutic development. Marseille, March 9, 2026 – After more than six months of collective effort, the Beacon™ technology is now installed on the B-SCREEN platform within IHU Méditerranée Infection in Marseille. This milestone marks a significant step forward in establishing […]
CRISTO 2026: a new scientific meeting dedicated to translational immunology
CRISTO 2026 On April 10, 2026, the first edition of CRISTO (Clinical Research Interfaces with Translational Objectives) will take place at the Palais du Pharo in Marseille. Led by: the Clinical Investigation Centre (CIC U1409) and jointly organized by: l’Assistance Publique – Hôpitaux de Marseille (AP-HM), Marseille Immunology Biocluster, Aix-Marseille Université, and Inserm CRISTO aims to […]
Expert insight – Daniel Olive : Why French Immunology Must Communicate to Lead
Why French Immunology Must Communicate to Lead ? Marseille, 16 February 2026 – France has long been home to outstanding immunology research. Our scientists contribute every day to advances in cancer, infectious diseases, transplantation, autoimmune disorders, and vaccine development. And yet, despite this central role, French immunology research still struggles to be recognized on the […]
Cell-Scale: A new strategic platform dedicated to Cell Therapies within MIB
Marseille, January 8, 2025 – Marseille Immunology Biocluster marks a new milestone in the development of translational immunology with the operational launch of Cell-Scale, a state-of-the-art technological platform dedicated to the engineering and development of innovative cell therapies. Designed to address the scientific and technological challenges of next-generation immunotherapies, Cell-Scale is now fully operational and […]
Meet Chafik Hamdad, Life Sciences Research Engineer for B-SCREEN
Within the B-SCREEN platform, Chafik Hamdad leverages his expertise in life sciences, biotechnology and biological data analysis to contribute to the identification of B cells and therapeutic antibodies from patient samples. Marseille, June 25, 2026 – Chafik Hamdad has spent several years in biotechnology R&D, developing expertise in next-generation sequencing, cellular and molecular biology, immuno-oncology and […]